Current status of sentinel lymph-node biopsy in patients with breast cancer (Q37779270)

23 August 2017

1 reference

title

Current status of sentinel lymph-node biopsy in patients with breast cancer (English)

1 reference

23 August 2017

0 references

0 references

1 reference

4

Abass Alavi

1 reference

23 August 2017

Gang Cheng

1

1 reference

23 August 2017

Stephanie Kurita

series ordinal

2

1 reference

23 August 2017

Drew A Torigian

series ordinal

3

1 reference

23 August 2017

language of work or name

1 reference

11 August 2010

1 reference

23 August 2017

number of pages

14

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

23 August 2017

volume

38

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

562-575

1 reference

Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

The impact of radiopharmaceutical particle size on the visualization and identification of sentinel nodes in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Molecular targeting of the lymphovascular system for imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Sentinel lymph node mapping of breast cancer via intradermal administration of Lymphoseek

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Properties and characteristics of the dyes injected to assist axillary sentinel node localization in breast surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

The benefits and limitations of sentinel lymph node biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Contraindications of sentinel lymph node biopsy: are there any really?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Blue angioedema of eyelip after patent blue injection for lymphatic mapping procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Skin necrosis following patent blue v injection for sentinel node detection during breast cancer excision: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Inflammatory cutaneous adverse effects of methylene blue dye injection for lymphatic mapping/sentinel lymphadenectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Allergy to technetium-labelled nanocolloidal albumin for sentinel node identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Lymphatic mapping in early stage breast cancer: comparison between periareolar and subdermal injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Rationale for superficial injection techniques in lymphatic mapping in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Subareolar versus peritumoral injection for location of the sentinel lymph node

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Standard versus pH-adjusted and lidocaine supplemented radiocolloid for patients undergoing sentinel-lymph-node mapping and biopsy for early breast cancer (PASSION-P trial): a double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy: a human cadaver study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Injection of (99m)Tc-labeled sulfur colloid the day before operation for breast cancer sentinel lymph node mapping is as successful as injection the day of operation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

The influence of radioisotope vehicle on breast sentinel node detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Does failure to visualize a sentinel node on preoperative lymphoscintigraphy predict a greater likelihood of axillary lymph node positivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

The Hybrid SPECT/CT as an additional lymphatic mapping tool in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Selective Sentinel Node Plus Additional Non-Sentinel Node Biopsy Based on an FDG-PET/CT Scan in Early Breast Cancer Patients: Single Institutional Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Removal of two sentinel nodes accurately stages the axilla in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Clinical relevance of multiple sentinel nodes in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Sentinel lymph node biopsy for breast cancer: how many nodes are enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Use of radiotracer for sentinel lymph node mapping in breast cancer optimizes staging independent of site of administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer: 2-site injection is more accurate than 1-site injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Subareolar Injection May Be More Accurate Than Other Techniques for Sentinel Lymph Node Biopsy in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Staging the axilla with selective sentinel node biopsy in patients with previous excision of non-palpable and palpable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Breast-conserving therapy and sentinel lymph node biopsy are feasible in cancer patients with previous implant breast augmentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Sentinel node biopsy in patients with previous breast aesthetic surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Reoperative sentinel lymph node biopsy after previous mastectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Sentinel node biopsy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Sentinel lymph node biopsy in patients with multifocal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Sentinel lymph node biopsy in multiple breast cancer using subareolar injection of the tracer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Clinical relevance of sentinel lymph nodes in the internal mammary chain in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Should the Hunt for Internal Mammary Chain Sentinel Nodes Begin? An Evaluation of 150 Breast Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

The clinical significance of sentinel lymph node micrometastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Significance of sentinel lymph node micrometastases in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Safety of sentinel node biopsy in pregnant patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Measurement of uterine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Comparative analysis of sentinel lymph node operation in male and female breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Sentinel lymph node biopsy is successful and accurate in male breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Additional tracer injection to improve the technical success rate of lymphoscintigraphy for sentinel node biopsy in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

The hidden sentinel node and SPECT/CT in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Prospective evaluation of factors influencing success rates of sentinel node biopsy in 814 breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Comparison of intraoperative frozen section analysis for sentinel lymph node biopsy during breast cancer surgery for invasive lobular carcinoma and invasive ductal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Factors influencing accuracy of axillary sentinel lymph node frozen section for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Sentinel node positive breast cancer patients who do not undergo axillary dissection: are they different?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

The Impact of Nonvisualization of Sentinel Nodes on Lymphoscintigraphy in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy for Advanced Breast Cancer: Results of Ganglion Sentinelle et Chimiothérapie Neoadjuvante, a French Prospective Multicentric Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1577-Z

Assessment of clinical palpation of the axilla as a criterion for performing the sentinel node procedure in breast cancer

21 January 2018

1 reference

12 December 2020

Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer

1 reference

12 December 2020

Recurrence rates in breast cancer patients with false-negative intraoperative evaluation of sentinel lymph nodes

1 reference

12 December 2020

Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy.

1 reference

12 December 2020

Mammary lymphoscintigraphy in breast cancer

1 reference

12 December 2020

Second axillary sentinel node biopsy for ipsilateral breast tumour recurrence

1 reference

12 December 2020

Lymphatic mapping in patients with breast carcinoma: reproducibility of lymphoscintigraphic results

1 reference

12 December 2020

A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases

1 reference

12 December 2020

Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients

1 reference

12 December 2020

Sentinel node in breast cancer procedural guidelines

1 reference

12 December 2020

Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011

1 reference

12 December 2020

Sentinel lymph node biopsy during pregnancy: initial clinical experience

1 reference

12 December 2020

Clinical assessment of lymph nodes in carcinoma of the breast

1 reference

12 December 2020

Prognostic and therapeutic impact of sentinel node micrometastasis in patients with invasive breast cancer

1 reference

12 December 2020

Clinical relevance of nonvisualized sentinel lymph nodes in unselected breast cancer patients during lymphoscintigraphy

1 reference

12 December 2020

Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma

1 reference

12 December 2020

Sentinel lymph node biopsy in male patients with early breast cancer

1 reference

12 December 2020

Radioguided sentinel lymph node biopsy in breast cancer surgery

1 reference

12 December 2020

Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?

1 reference

12 December 2020

Intradermal radioisotope injection is superior to subdermal injection for the identification of the sentinel node in breast cancer patients

1 reference

12 December 2020

Radiopharmaceuticals in sentinel lymph-node detection - an overview.

1 reference

12 December 2020

Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.

1 reference

12 December 2020

Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years

1 reference

12 December 2020

Frozen section in axillary sentinel lymph nodes for diagnosis of breast cancer micrometastasis

1 reference

12 December 2020

Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy

1 reference

12 December 2020

Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study

1 reference

12 December 2020

Multicentric breast cancer: a new indication for sentinel node biopsy--a multi-institutional validation study

1 reference

12 December 2020

The sentinel lymph node procedure for patients with preoperative diagnosis of ductal carcinoma in situ: risk factors for unsuspected invasive disease and for metastatic sentinel lymph nodes

1 reference

12 December 2020

The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology

1 reference

12 December 2020

Occult metastases in sentinel nodes of 200 patients with operable breast cancer

1 reference

12 December 2020

Sentinel lymph node identification in breast cancer: a comparison study of deep versus superficial injection of radiopharmaceutical

1 reference

12 December 2020

Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection

1 reference

12 December 2020

Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes

1 reference

12 December 2020

Sentinel node localization in breast cancer

1 reference

12 December 2020

Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies

1 reference

12 December 2020

Factors affecting visualization rates of internal mammary sentinel nodes during lymphoscintigraphy.

1 reference

12 December 2020

Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?

1 reference

12 December 2020

The value of intraoperative frozen section examination of sentinel lymph nodes in breast cancer

1 reference

12 December 2020

Can the sentinel lymph node technique affect decisions to offer internal mammary chain irradiation?

1 reference

12 December 2020

The feasibility of sentinel node biopsy in the previously treated breast

1 reference

12 December 2020

Lymphatic mapping and sentinel lymphadenectomy for breast cancer

1 reference

12 December 2020

The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial

1 reference

12 December 2020

10.1007/S00259-010-1577-Z

Identifiers

DOI

1 reference

23 August 2017

1 reference